Casdin Capital, LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.7%.

Quarter-by-quarter ownership
Casdin Capital, LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$39,538,000
-26.7%
2,650,000
+26.2%
1.11%
-17.1%
Q3 2021$53,970,000
+68.9%
2,100,000
+71.4%
1.34%
+65.6%
Q2 2021$31,948,000
-30.4%
1,225,000
-5.8%
0.81%
-40.7%
Q1 2021$45,890,000
+92.4%
1,300,000
+37.6%
1.37%
+93.4%
Q4 2020$23,852,000
-33.1%
945,0000.0%0.71%
-55.7%
Q3 2020$35,636,000
+33.2%
945,000
+51.2%
1.60%
+0.8%
Q2 2020$26,763,000
+175.3%
625,000
+25.0%
1.58%
+53.5%
Q1 2020$9,720,000500,0001.03%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$46,213,00013.24%
Wildcat Capital Management, LLC 1,716,370$44,111,0005.71%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$481,009,0004.77%
Copernicus Capital Management, LLC 15,000$386,0004.67%
Coastal Bridge Advisors, LLC 301,240$7,742,0001.79%
Lombard Odier Asset Management (Switzerland) SA 914,416$23,500,0001.46%
Casdin Capital, LLC 2,100,000$53,970,0001.34%
Pier Capital, LLC 450,182$11,570,0001.20%
Ghost Tree Capital, LLC 150,000$3,855,0001.13%
Sessa Capital IM, L.P. 750,000$19,275,0000.95%
View complete list of ALLOGENE THERAPEUTICS INC shareholders